NEON Stock Overview
NeonMind Biosciences Inc. engages in the drug development of psychedelic compounds in Canada.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
NeonMind Biosciences Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.005 |
| 52 Week High | CA$3.30 |
| 52 Week Low | CA$0.15 |
| Beta | -0.91 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | -99.79% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -99.98% |
Recent News & Updates
Recent updates
Shareholder Returns
| NEON | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | 0% | -6.6% | 0.7% |
| 1Y | -99.8% | 41.0% | 4.9% |
Return vs Industry: NEON underperformed the Canadian Pharmaceuticals industry which returned -29.5% over the past year.
Return vs Market: NEON underperformed the Canadian Market which returned -0.7% over the past year.
Price Volatility
| NEON volatility | |
|---|---|
| NEON Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 13.8% |
| Market Average Movement | 9.0% |
| 10% most volatile stocks in CA Market | 18.1% |
| 10% least volatile stocks in CA Market | 3.0% |
Stable Share Price: NEON has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine NEON's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2019 | n/a | Rob Tessarolo | www.neonmindbiosciences.com |
NeonMind Biosciences Inc. engages in the drug development of psychedelic compounds in Canada. It operates in two divisions, Pharmaceutical and Medical Services. The company’s lead product candidate is the NEO-001, a high-dose psilocybin for the treatment of obesity.
NeonMind Biosciences Inc. Fundamentals Summary
| NEON fundamental statistics | |
|---|---|
| Market cap | CA$5.62k |
| Earnings (TTM) | -CA$934.09k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio0.0x
P/E RatioIs NEON overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NEON income statement (TTM) | |
|---|---|
| Revenue | CA$0 |
| Cost of Revenue | CA$0 |
| Gross Profit | CA$0 |
| Other Expenses | CA$934.09k |
| Earnings | -CA$934.09k |
Last Reported Earnings
Feb 28, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.83 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -78.6% |
How did NEON perform over the long term?
See historical performance and comparison